# AIM ImmunoTech Inc.: filings

AIM · NYSE · CIK 946644 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aim.md) · [Financials](/companies/aim/financials.md) · [Filings](/companies/aim/filings.md) · [Insiders](/companies/aim/insiders.md)

## Reports and events: 415 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 451, 8-K 269, 10-Q 53, CORRESP 49, DEFA14A 47, 424B5 44, UPLOAD 34, DFAN14A 25, EFFECT 21, DEF 14A 20, 10-K 18, 4/A 14, S-1 13, S-1/A 13, 3 12, 424B3 11, S-8 11, PRE 14A 10, SC 13D/A 10, CT ORDER 8, SC 13G 8, 10-Q/A 7, DEFC14A 6, PREC14A 6, S-3 6, SC 13G/A 6, 8-K/A 5, S-3/A 5, D 4, POS AM 4, PRER14A 4, 10-K/A 3, 424B4 3, 8-A12B/A 3, SC 13D 3, PRRN14A 2, S-8 POS 2, SCHEDULE 13G 2, 8-A12B 1, 8-A12G/A 1, ARS 1, CERTNYS 1, D/A 1, DEFR14A 1, NT 10-K 1, NT 10-Q 1, RW 1, SCHEDULE 13D/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 16:05 ET | [DEF 14A](/filings/0001493152-26-045102.md) | Proxy statement, period 2026-09-30 | 0001493152-26-045102 |
| 2026-09-14 | 16:35 ET | [8-K](/filings/0001493152-26-042592.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042592 |
| 2026-09-10 | 16:35 ET | [8-K](/filings/0001493152-26-042196.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042196 |
| 2026-09-04 | 16:05 ET | [8-K](/filings/0001493152-26-041537.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041537 |
| 2026-08-11 | 08:40 ET | [8-K](/filings/0001493152-26-036996.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036996 |
| 2026-08-10 | 08:40 ET | [8-K](/filings/0001493152-26-036753.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036753 |
| 2026-08-07 | 16:35 ET | [10-Q](/filings/0001493152-26-036609.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036609 |
| 2026-08-06 | 17:22 ET | [8-K](/filings/0001493152-26-036408.md) | 1.01 Entry into a material agreement; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-26-036408 |
| 2026-08-05 | 08:00 ET | [8-K](/filings/0001493152-26-036104.md) | 1.02 Termination of a material agreement | 0001493152-26-036104 |
| 2026-07-16 | 16:05 ET | [8-K](/filings/0001493152-26-033514.md) | 5.07 Shareholder vote results | 0001493152-26-033514 |
| 2026-06-25 | 08:55 ET | [DEF 14A](/filings/0001493152-26-030043.md) | Proxy statement, period 2026-06-25 | 0001493152-26-030043 |
| 2026-06-18 | 08:00 ET | [S-1](/filings/0001493152-26-029193.md) | Registration statement | 0001493152-26-029193 |
| 2026-06-15 | 08:01 ET | [8-K](/filings/0001493152-26-028615.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028615 |
| 2026-06-11 | 16:15 ET | [8-K](/filings/0001493152-26-028283.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028283 |
| 2026-06-10 | 16:59 ET | [8-K](/filings/0001493152-26-028129.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-028129 |
| 2026-06-08 | 16:05 ET | [S-1](/filings/0001493152-26-027714.md) | Registration statement | 0001493152-26-027714 |
| 2026-06-04 | 09:00 ET | [8-K](/filings/0001493152-26-027210.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027210 |
| 2026-05-21 | 11:31 ET | [8-K](/filings/0001493152-26-024760.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024760 |
| 2026-05-19 | 08:03 ET | [8-K](/filings/0001493152-26-024353.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-024353 |
| 2026-05-15 | 16:05 ET | [10-Q](/filings/0001493152-26-023750.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023750 |
| 2026-05-14 | 08:45 ET | [8-K](/filings/0001493152-26-022891.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-022891 |
| 2026-05-12 | 16:27 ET | [8-K](/filings/0001493152-26-022499.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-022499 |
| 2026-05-08 | 08:50 ET | [8-K](/filings/0001493152-26-021863.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-021863 |
| 2026-04-10 | 16:33 ET | [8-K](/filings/0001493152-26-016179.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-016179 |
| 2026-03-27 | 17:30 ET | [10-K](/filings/0001493152-26-013301.md) | Annual report, period 2025-12-31 | 0001493152-26-013301 |
| 2026-03-06 | 17:15 ET | [8-K](/filings/0001493152-26-009190.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009190 |
| 2026-02-10 | 16:35 ET | [S-1/A](/filings/0001493152-26-005975.md) | Registration statement, amended | 0001493152-26-005975 |
| 2026-02-05 | 08:40 ET | [8-K](/filings/0001493152-26-005208.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005208 |
| 2026-01-29 | 16:31 ET | [S-1/A](/filings/0001493152-26-004238.md) | Registration statement, amended | 0001493152-26-004238 |
| 2026-01-23 | 12:53 ET | [S-1/A](/filings/0001493152-26-003343.md) | Registration statement, amended | 0001493152-26-003343 |
| 2026-01-20 | 07:00 ET | [8-K](/filings/0001493152-26-002728.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-002728 |
| 2026-01-12 | 17:19 ET | [8-K](/filings/0001493152-26-001898.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-001898 |
| 2025-12-17 | 16:30 ET | [8-K](/filings/0001493152-25-028156.md) | 5.07 Shareholder vote results | 0001493152-25-028156 |
| 2025-12-12 | 18:21 ET | [S-1](/filings/0001493152-25-027319.md) | Registration statement | 0001493152-25-027319 |
| 2025-11-19 | 07:00 ET | [8-K](/filings/0001493152-25-024156.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-024156 |
| 2025-11-17 | 16:36 ET | [10-Q](/filings/0001493152-25-023894.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023894 |
| 2025-10-29 | 17:16 ET | [8-K](/filings/0001493152-25-020102.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-020102 |
| 2025-10-29 | 16:30 ET | [DEF 14A](/filings/0001493152-25-020083.md) | Proxy statement, period 2025-10-29 | 0001493152-25-020083 |
| 2025-10-20 | 09:16 ET | [8-K](/filings/0001493152-25-018583.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-018583 |
| 2025-08-14 | 16:15 ET | [10-Q](/filings/0001493152-25-011986.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011986 |
| 2025-07-31 | 16:45 ET | [8-K](/filings/0001641172-25-021762.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021762 |
| 2025-07-28 | 09:20 ET | [8-K](/filings/0001493152-25-011441.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011441 |
| 2025-07-22 | 13:21 ET | [S-1/A](/filings/0001641172-25-020534.md) | Registration statement, amended | 0001641172-25-020534 |
| 2025-07-15 | 15:05 ET | [S-1/A](/filings/0001493152-25-011234.md) | Registration statement, amended | 0001493152-25-011234 |
| 2025-06-20 | 16:30 ET | [8-K](/filings/0001641172-25-015861.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-015861 |
| 2025-06-12 | 16:50 ET | [8-K](/filings/0001641172-25-014899.md) | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014899 |
| 2025-05-15 | 16:45 ET | [10-Q](/filings/0001641172-25-011033.md) | Quarterly report, period 2025-03-31 | 0001641172-25-011033 |
| 2025-05-01 | 20:23 ET | [8-K](/filings/0001641172-25-007954.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-007954 |
| 2025-04-07 | 17:56 ET | [8-K](/filings/0001641172-25-002858.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002858 |
| 2025-04-04 | 10:30 ET | [8-K](/filings/0001641172-25-002702.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-002702 |

Page 1 of 9. [Older](/companies/aim/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 12:13 ET. No prices; not investment advice.